- Home
- SAP vs NVS Comparison
SAP vs NVS Comparison
Compare SAP & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAP
- NVS
- Stock Information
- Founded
- SAP 1972
- NVS 1895
- Country
- SAP Germany
- NVS Switzerland
- Employees
- SAP N/A
- NVS N/A
- Industry
- SAP Computer Software: Prepackaged Software
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- SAP Technology
- NVS Health Care
- Exchange
- SAP Nasdaq
- NVS Nasdaq
- Market Cap
- SAP 272.8B
- NVS 230.5B
- IPO Year
- SAP 1998
- NVS 1991
- Fundamental
- Price
- SAP $235.02
- NVS $103.10
- Analyst Decision
- SAP Buy
- NVS Hold
- Analyst Count
- SAP 7
- NVS 6
- Target Price
- SAP $252.33
- NVS $121.25
- AVG Volume (30 Days)
- SAP 864.0K
- NVS 1.4M
- Earning Date
- SAP 10-21-2024
- NVS 10-29-2024
- Dividend Yield
- SAP 1.02%
- NVS 3.67%
- EPS Growth
- SAP N/A
- NVS 130.53
- EPS
- SAP 2.59
- NVS 8.58
- Revenue
- SAP $37,102,386,780.00
- NVS $49,940,000,000.00
- Revenue This Year
- SAP $9.77
- NVS $10.04
- Revenue Next Year
- SAP $11.12
- NVS $4.55
- P/E Ratio
- SAP $88.14
- NVS $11.67
- Revenue Growth
- SAP 8.00
- NVS 8.92
- 52 Week Low
- SAP $148.38
- NVS $92.35
- 52 Week High
- SAP $243.01
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- SAP 53.75
- NVS 24.72
- Support Level
- SAP $227.52
- NVS $102.40
- Resistance Level
- SAP $234.24
- NVS $103.42
- Average True Range (ATR)
- SAP 2.96
- NVS 0.91
- MACD
- SAP -0.66
- NVS -0.31
- Stochastic Oscillator
- SAP 58.37
- NVS 7.93
About SAP SAP SE ADS
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small- to medium-size enterprises.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.